More Articles Back to Article
New pregnancy prevention drug gains FDA nod
Mayne Pharma has gained the FDA's approval for its contraceptive Nextstellis, or drospirenone and estetrol, which is expected to become commercially available by the end of June. eMPR (4/16)
Read full article now.
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!